Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:05:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page removes the generic government funding/operating-status notice.
    Difference
    0.3%
    Check dated 2025-11-17T15:11:56.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Version history shows multiple updates to core trial details (recruitment status, study status, and site/ contact information) across several versions. These changes reflect updates to current trial progress and site information.
    Difference
    0.0%
    Check dated 2025-11-03T01:32:54.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and a new version number (v3.2.0) replacing the old one (v3.1.0); reflects status and version changes rather than substantive feature additions.
    Difference
    7%
    Check dated 2025-10-05T10:26:37.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Major version update to v3.1.0 with a new study status entry and date; older revision v3.0.2 and its date removed.
    Difference
    0.9%
    Check dated 2025-09-28T03:23:03.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release, and the 'Back to Top' element was removed; overall, core content remains unchanged.
    Difference
    0.4%
    Check dated 2025-09-13T17:39:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.